ANTIMYELIN BASIC-PROTEIN AND ANTIMYELIN ANTIBODY-PRODUCING CELLS IN MULTIPLE-SCLEROSIS

The B‐Cell response to myelin and myelin basic protein was studied in patients with multiple sclerosis and in patients with acute aseptic meningoencephalitis by using a nitrocellulose immunospot assay. This method allows detection of single cells producing antibodies. Twenty‐seven (79%) of 34 patients with multiple sclerosis had cells producing IgG antibodies against myelin, and 11 (57%) of 19 had cells producing IgG antibodies against myelin basic protein in cerebrospinal fluid (CSF), with mean values of 30 and 14 per 104 mononuclear cells, respectively. Total numbers of IgG‐producing cells occurred at a mean number of 75 per 104 CSF Cells. Cells producing antimyelin or anti–myelin basic protein antibodies of IgA or IgM isotypes were rarely found in CSF. Patients with acute aseptic meningoencephalitis less frequently showed CSF cells producing IgG antibodies against myelin and myelin basic protein. No cells producing antibodies against myelin or myelin basic protein were detected in peripheral blood of patients with multiple sclerosis or meningoencephalitis. Thus, a majority of patients with multiple sclerosis had CSF cells that produced IgG antibodies against myelin and myelin basic protein. These cells comprised a large proportion of the total IgG‐producing cells. A pronounced B‐cell response against autoantigens produced at the target for immune attack might be important in the pathogenesis of multiple sclerosis. Copyright © 1990 American Neurological Association